Skip to Main Content

Author Details

Carl A K Borrebaeck
Lund University
1977
295
50
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37104747An artificial intelligence-powered, patient-centric digital tool for self-management of chronic pain: a prospective, multicenter clinical trial.Pain Med2023
35297213Transcriptional profiling demonstrates altered characteristics of CD8<sup>+</sup> cytotoxic T-cells and regulatory T-cells in TP53-mutated acute myeloid leukemia.Cancer Med2022
36052232One-year recovery from breast cancer: Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life.Front Oncol2022
32780268The Value of a New Diagnostic Test for Prostate Cancer: A Cost-Utility Analysis in Early Stage of Development.Pharmacoecon Open2021
33580906Identification of a serum biomarker signature associated with metastatic prostate cancer.Proteomics Clin Appl2021
34070600Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers.Proteomes2021
33467141Fluorescence Signal Enhancement in Antibody Microarrays Using Lightguiding Nanowires.Nanomaterials (Basel)2021
32398074Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in Sweden.Health Qual Life Outcomes2020
33046876Animal-free alternatives and the antibody iceberg.Nat Biotechnol2020
33269004Psychological Resilience and Health-Related Quality of Life in Swedish Women with Newly Diagnosed Breast Cancer.Cancer Manag Res2020
32719533Animal-derived-antibody generation faces strict reform in accordance with European Union policy on animal use.Nat Methods2020
32620783Multiplex profiling of serum proteins in solution using barcoded antibody fragments and next generation sequencing.Commun Biol2020
32415238Reproducibility: bypass animals for antibody production.Nature2020
30720708Skin Sensitization Testing-What's Next?Int J Mol Sci2019
28778816Combination of phage and Gram-positive bacterial display of human antibody repertoires enables isolation of functional high affinity binders.N Biotechnol2018
30081937A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients: study protocol of the SCAN-B resilience study.BMC Cancer2018
30106639Serum Biomarker Signature-Based Liquid Biopsy for Diagnosis of Early-Stage Pancreatic Cancer.J Clin Oncol2018
29702529The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.Pancreas2018
27694630Deciphering systemic lupus erythematosus-associated serum biomarkers reflecting apoptosis and disease activity.Lupus2017
28214915Evaluation of the GARD assay in a blind Cosmetics Europe study.ALTEX2017
28154374Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer.Nat Rev Cancer2017
28125016Testing Human Skin and Respiratory Sensitizers-What Is Good Enough?Int J Mol Sci2017
28501851Implementing liquid biopsies into clinical decision making for cancer immunotherapy.Oncotarget2017
28650989Tumor tissue protein signatures reflect histological grade of breast cancer.PLoS One2017
26703809Advancing the global proteome survey platform by using an oriented single chain antibody fragment immobilization approach.N Biotechnol2016
27590051Generation and analyses of human synthetic antibody libraries and their application for protein microarrays.Protein Eng Des Sel2016
27600082Evaluation of Solid Supports for Slide- and Well-Based Recombinant Antibody Microarrays.Microarrays (Basel)2016
27858932Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study.Blood Cancer J2016
27450382Animal-Friendly Affinity Reagents: Replacing the Needless in the Haystack.Trends Biotechnol2016
27471297Animal-based antibodies: Obsolete.Science2016
27414037Technical Advances of the Recombinant Antibody Microarray Technology Platform for Clinical Immunoproteomics.PLoS One2016
27522951Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis.Mol Oncol2016
25306393Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer.Mol Oncol2015
26465682Advanced technologies and diagnostic spin-outs: an interview with Carl Borrebaeck.Expert Rev Mol Diagn2015
26587286A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma.Int J Proteomics2015
25760038Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature.PLoS One2015
24497355Recombinant antibody microarray for profiling the serum proteome of SLE.Methods Mol Biol2014
25196118Identification of plasma protein profiles associated with risk groups of prostate cancer patients.Proteomics Clin Appl2014
24982817Preclinical evaluation of (111)In-DTPA-INCA-X anti-Ku70/Ku80 monoclonal antibody in prostate cancer.Am J Nucl Med Mol Imaging2014
25172394Molecular design of recombinant scFv antibodies for site-specific photocoupling to β-cyclodextrin in solution and onto solid support.Biochim Biophys Acta2014
24763547Multiplexing of miniaturized planar antibody arrays for serum protein profiling--a biomarker discovery in SLE nephritis.Lab Chip2014
24754901Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays.Leuk Res2014
24946919Miniaturization of multiplexed planar recombinant antibody arrays for serum protein profiling.Bioanalysis2014
24960426Generation of miniaturized planar ecombinant antibody arrays using a microcantilever-based printer.Nanotechnology2014
24517095Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency.BMC Pharmacol Toxicol2014
24515491Antibody array generation and use.Methods Mol Biol2014
24675087Genomic allergen rapid detection in-house validation--a proof of concept.Toxicol Sci2014
23032079The GARD assay for assessment of chemical skin sensitizers.Toxicol In Vitro2013
24063262Protein expression profiling of formalin-fixed paraffin-embedded tissue using recombinant antibody microarrays.J Proteome Res2013
23923007Nuclear T-STAR protein expression correlates with HER2 status, hormone receptor negativity and prolonged recurrence free survival in primary breast cancer and decreased cancer cell growth in vitro.PLoS One2013
  • 1 - 50 of 295

Recommended Authors

Paula D??ez
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Career Start Year 2012
Number of shared co-authors 3
Walead Ebrahimizadeh
Current affiliation: IMV Inc.
Career Start Year 2011
Number of shared co-authors 0
Elisa Pin
KTH Royal Institute of Technology
Career Start Year 2007
Number of shared co-authors 7
Heather L Howie
University of Virginia School of Medicine.
Career Start Year 2004
Number of shared co-authors 0
Manuel Fuentes
Cancer Research Centre (IBMCC/CSIC/USAL/IBSAL)
Career Start Year 2002
Number of shared co-authors 4
Ning Jiang
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
Ningyan Zhang
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Career Start Year 2000
Number of shared co-authors 0
Susanne Gr??slund
Karolinska Institutet
Career Start Year 1999
Number of shared co-authors 3
Paul A Ramsland
College of Science, RMIT University
Career Start Year 1997
Number of shared co-authors 0
Vladimir Vigdorovich
Center for Global Infectious Disease Research, Seattle Children's Hospital
Career Start Year 1997
Number of shared co-authors 0
Jaume Pons
Pfizer Inc.
Career Start Year 1994
Number of shared co-authors 0
Yu-Tsueng Liu
University of California San Diego
Career Start Year 1994
Number of shared co-authors 0
Brygida Bisikirska
Columbia University
Career Start Year 1993
Number of shared co-authors 0
Zhiqiang An
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
Ingmarie H??id??n-Guthenberg
Stockholm University
Career Start Year 1989
Number of shared co-authors 8
Kanury V S Rao
Translational Health Science and Technology Institute
Career Start Year 1987
Number of shared co-authors 0
Joshua LaBaer
Biodesign Institute, Arizona State University
Career Start Year 1986
Number of shared co-authors 8
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 4
Leslie Lobel
Ben-Gurion University of the Negev
Career Start Year 1984
Number of shared co-authors 0
Jos?? Ignacio Casal
Max-Planck-Institut fur Entwicklungsbiologie
Career Start Year 1984
Number of shared co-authors 2
David R Karp
University of Texas Southwestern Medical Center
Career Start Year 1981
Number of shared co-authors 0
Brian Seed
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year 1980
Number of shared co-authors 0
Thomas E Fehniger
Biomedical Center, Lund University
Career Start Year 1979
Number of shared co-authors 5
Peter S Linsley
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 0
Peter Nilsson
Linkoping University
Career Start Year 1978
Number of shared co-authors 21
Peter A Kiener
BioKien LLC
Career Start Year 1976
Number of shared co-authors 0
Jonathan Braun
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 1
Edouard C Nice
Monash University
Career Start Year 1971
Number of shared co-authors 6
David W Scott
University of British Columbia
Career Start Year 1965
Number of shared co-authors 0
Leroy Hood
Center for Phenomic Health, The Buck Institute for Research on Aging
Career Start Year 1961
Number of shared co-authors 3

Collaborators

Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 8
Ulrika Axelsson
KTH - Royal Institute of Technology
Co-authored papers 8
Karin Jirstr??m
Lund University
Co-authored papers 6
Helena Persson
Lund University Cancer Centre
Co-authored papers 6
Anders Bjartell
Skane University Hospital, Lund University
Co-authored papers 5
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Co-authored papers 4
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 3
Gy??rgy Marko-Varga
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Co-authored papers 2
John D Rioux
Co-authored papers 2
Fredrik Pont??n
Uppsala University
Co-authored papers 2
Henry Rodriguez
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 2
Henning Hermjakob
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 2
Olli Kallioniemi
Karolinska Institute
Co-authored papers 2
Antoine de Daruvar
Co-authored papers 2
Sophia Hober
KTH Royal Institute of Technology
Co-authored papers 2
Sandra Orchard
EMBL's European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 2
Johan Rockberg
KTH - Royal Institute of Technology
Co-authored papers 2
Manfred Koegl
Boehringer Ingelheim RCV GmbH & Co. KG
Co-authored papers 2
Darran P O'Connor
UCD Conway Institute, University College Dublin
Co-authored papers 2
Caroline Kampf
Uppsala University
Co-authored papers 2
Magnus Abrahamson
Skane University Hospital, Lund University
Co-authored papers 2
Elton Rexhepaj
UCD Conway Institute, University College Dublin
Co-authored papers 2
Sami Kilpinen
University of Helsinki
Co-authored papers 2
Per-Ake Nygren
Royal Institute of Technology
Co-authored papers 1
Charlie E Massie
University of Cambridge
Co-authored papers 1
Børge G Nordestgaard
Co-authored papers 1
Tara Hiltke
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Co-authored papers 1
Costas A Lyssiotis
Co-authored papers 1
Kristina Magnusson
Uppsala University
Co-authored papers 1
Frank Gibson
Newcastle University
Co-authored papers 1
Release 1.2